ACTEMRA LEAD FIRST GIM
A content example of a bi-annual Actemra Global Implementation Meeting (GIM) involving large amounts of animation and film work conveying various worldwide brand initiatives, as well as numerous experiential activities and digitally-led implementation and disease awareness programmes (such as Best Practice and RA Unspoken).
An imaginative 3D animation announces Actemra’s new global strategy to become first line choice in biologic monotherapy.
ACTEMRA GLOBAL BRAND REPOSITIONING
The aim was to establish the brand as the optimum monotherapy in the RA market with a simple, disruptive core global campaign that stood out in a category where lifestyle imagery dominated. Within 3 years this brand became the leading monotherapy RA biologic in the world.
This campaign extended through advertising and sales materials, to congresses, exhibitions, internal meetings and beyond, and has been successfully adopted by major markets worldwide.
actemra monotherapy stands out
This 3D animation promotes ACTEMRA’s clean side-effect’s profile vs established TNFi brands, used in combination
with methotrexate.
